LPL Financial LLC increased its holdings in KKR & Co. Inc. (NYSE:KKR – Free Report) by 36.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 702,200 shares of the asset manager’s stock after purchasing an additional 187,317 shares during the period. LPL Financial LLC owned approximately 0.08% of KKR & Co. Inc. worth $103,862,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the business. Farmers & Merchants Investments Inc. increased its holdings in shares of KKR & Co. Inc. by 17.8% during the 4th quarter. Farmers & Merchants Investments Inc. now owns 430 shares of the asset manager’s stock valued at $64,000 after acquiring an additional 65 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its position in KKR & Co. Inc. by 0.4% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 16,427 shares of the asset manager’s stock worth $2,430,000 after purchasing an additional 69 shares during the period. Ballentine Partners LLC grew its holdings in KKR & Co. Inc. by 1.2% during the fourth quarter. Ballentine Partners LLC now owns 5,721 shares of the asset manager’s stock valued at $846,000 after purchasing an additional 70 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of KKR & Co. Inc. by 5.7% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,289 shares of the asset manager’s stock valued at $191,000 after purchasing an additional 70 shares during the period. Finally, Wealthcare Advisory Partners LLC lifted its stake in shares of KKR & Co. Inc. by 0.7% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 10,974 shares of the asset manager’s stock worth $1,623,000 after buying an additional 73 shares during the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at KKR & Co. Inc.
In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total value of $197,760,000.00. Following the transaction, the insider now owns 19,260,971 shares of the company’s stock, valued at approximately $634,841,604.16. The trade was a 23.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Stock Up 0.2 %
KKR & Co. Inc. Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.175 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.70 annualized dividend and a yield of 0.57%. KKR & Co. Inc.’s dividend payout ratio is 21.02%.
Analysts Set New Price Targets
Several brokerages recently commented on KKR. Barclays dropped their target price on shares of KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating on the stock in a report on Wednesday, February 5th. HSBC cut KKR & Co. Inc. from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $153.00 to $173.00 in a research report on Thursday, January 30th. Keefe, Bruyette & Woods lowered their target price on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating on the stock in a report on Monday, January 13th. Wells Fargo & Company upgraded KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and cut their price target for the stock from $150.00 to $141.00 in a report on Thursday, March 20th. Finally, Oppenheimer raised their price objective on shares of KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.79.
Get Our Latest Research Report on KKR
About KKR & Co. Inc.
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Featured Stories
- Five stocks we like better than KKR & Co. Inc.
- How to Calculate Return on Investment (ROI)
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Growth Stocks: What They Are, Examples and How to Invest
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.